UnitedHealth Group Signals Recovery with Raised 2026 Guidance

UnitedHealth Group (NYSE: UNH) is demonstrating a clear recovery trajectory in 2026, rebounding from a volatile 2025 characterized by regulatory scrutiny and leadership changes. The company recently raised its full-year earnings per share (EPS) guidance, signaling confidence in its operational stability and growth prospects. The shift comes as the integrated healthcare provider leverages its massive scale to optimize costs. With a dominant position as the largest health insurer and physician employer in the U.S., UNH is utilizing pricing discipline and better cost management to stabilize its margins. Financial results for the first quarter highlight this turnaround, with the company reporting revenue of $111.7 billion. EPS stood at $6.90, with adjusted EPS at $7.23. Consequently, the company raised its annual EPS guidance to $17.35, with an adjusted target of $18.25. A critical performance metric, the Medical Care Ratio (MCR), improved to 83.9%, down from 84.8% in the same period last year. Operating margins rose to 6.6% from 6.2% year-over-year, despite a slight 1% dip in operating earnings to $9 billion. From a valuation perspective, the stock is currently trading at approximately 19 times projected earnings—a significant discount from the 30x multiples seen in early 2025—while offering a 2.5% dividend yield.